AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyrow MF 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Rowlinges Life Science

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glyrow MF 80mg/500mg Tablet

Diabetace Duo 80mg/500mg tablets are classified as anti-diabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabetace Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate hypoglycemia. Alcohol consumption should be limited due to its potential to lower blood sugar. Additional possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Glyrow MF 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glyrow MF 80mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyrow MF 80mg/500mg tablets should be administered with a meal.

Common Side effects of Glyrow MF 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glyrow MF 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. It's recommended to take Glyrow MF 80mg/500mg with food.

How Glyrow MF 80mg/500mg Tablet works:

Gliclazide and Metformin, combined as Glyrow MF 80mg/500mg tablets, offer dual action against diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyrow MF 80mg/500mg Tablet and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glyrow MF 80mg/500mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glyrow MF 80mg/500mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glyrow MF 80mg/500mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glyrow MF 80mg/500mg Tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyrow MF 80mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose of Glyrow MF 80mg/500mg tablets is typical; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glyrow MF 80mg/500mg Tablet :

Should you forget a Glyrow MF 80mg/500mg Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glyrow MF 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glyrow MF 80mg/500mg Tablet

Glyrow MF 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glyrow MF is not suitable for type 1 diabetes.
Glyrow MF 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glyrow MF 80mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases if you skip meals, drink alcohol, overexercise, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Glyrow MF 80mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glyrow MF 80mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Glyrow MF 80mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Glyrow MF 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by individuals with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining Glyrow MF 80mg/500mg tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glyrow MF 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glyrow MF 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glyrow MF 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glyrow MF 80mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glyrow MF 80mg/500mg Tablets and seek immediate medical attention.
Prolonged Glyrow MF 80mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glyrow MF 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining Glyrow MF 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glyrow MF 80mg/500mg Tabl...
78
MRP 90
13% off